You are in the accessibility menu

Please use this identifier to cite or link to this item: http://acervodigital.unesp.br/handle/11449/65495
Full metadata record
DC FieldValueLanguage
dc.contributor.authorViero, Rosa Marlene-
dc.contributor.authorSoares, Vitor A.-
dc.date.accessioned2014-05-27T11:19:36Z-
dc.date.accessioned2016-10-25T18:15:10Z-
dc.date.available2014-05-27T11:19:36Z-
dc.date.available2016-10-25T18:15:10Z-
dc.date.issued1998-08-13-
dc.identifierhttp://dx.doi.org/10.3109/08860229809045148-
dc.identifier.citationRenal Failure, v. 20, n. 4, p. 565-571, 1998.-
dc.identifier.issn0886-022X-
dc.identifier.urihttp://hdl.handle.net/11449/65495-
dc.identifier.urihttp://acervodigital.unesp.br/handle/11449/65495-
dc.description.abstractRats treated with two injections of adriamycin (week 0 and week 12) developed glomerusclerosis and severe tubulointerstitial lesions as described in the literature. In addition, a number of glomerular alterations were present. These included capillary loop dilation, insudation of eosinophilic material, necrosis, duplication of the glomerular basement membrane, severe mesangiolysis with disruption of the mesangial matrix and segmental double- contours. The renal arterioles and interlobular arteries showed endothelial cell swelling. The subendothelial space was infiltrated by fibrinoid material and there was intensive fibrinoid necrosis of the wall of both arteries and arterioles extending into the glomerular tuft. These alterations were very similar to those observed in the hemolytic uremic syndrome. This observation suggests that the two injections of adriamycin, with a long interval in between them, might induce renal lesions similar to those observed in the hemolytic uremic syndrome.en
dc.format.extent565-571-
dc.language.isoeng-
dc.sourceScopus-
dc.subjectAdriamycin-
dc.subjectHemolytic uremic syndrome-
dc.subjectdoxorubicin-
dc.subjecthydroxyproline-
dc.subjectserum albumin-
dc.subjectsodium chloride-
dc.subjectanimal experiment-
dc.subjectanimal model-
dc.subjectanimal tissue-
dc.subjectcontrolled study-
dc.subjectcreatinine clearance-
dc.subjectglomerulosclerosis-
dc.subjectglomerulus basement membrane-
dc.subjectglomerulus capillary-
dc.subjecthemolytic uremic syndrome-
dc.subjectinterstitial nephritis-
dc.subjectkidney artery-
dc.subjectkidney disease-
dc.subjectmale-
dc.subjectmesangium-
dc.subjectnonhuman-
dc.subjectpriority journal-
dc.subjectrat-
dc.subjectAnimals-
dc.subjectAntineoplastic Agents-
dc.subjectDoxorubicin-
dc.subjectGlomerulonephritis-
dc.subjectHemolytic-Uremic Syndrome-
dc.subjectKidney Glomerulus-
dc.subjectMale-
dc.subjectNephritis, Interstitial-
dc.subjectRats-
dc.subjectRats, Wistar-
dc.subjectTime Factors-
dc.titleThe hemolytic uremic syndrome as a complication of adriamycin nephropathyen
dc.typeoutro-
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)-
dc.description.affiliationDepartment of Pathology Botucatu Medical School, Botucatu-
dc.description.affiliationDepartment of Internal Medicine Division of Nephrology Botucatu Medical School, Botucatu-
dc.description.affiliationBotucatu Medical School Depto. Internal Medicine Division of Nephrology, P O Box 584, Botucatu, DP, 18618-970-
dc.description.affiliationUnespDepartment of Pathology Botucatu Medical School, Botucatu-
dc.description.affiliationUnespDepartment of Internal Medicine Division of Nephrology Botucatu Medical School, Botucatu-
dc.description.affiliationUnespBotucatu Medical School Depto. Internal Medicine Division of Nephrology, P O Box 584, Botucatu, DP, 18618-970-
dc.identifier.doi10.3109/08860229809045148-
dc.rights.accessRightsAcesso restrito-
dc.relation.ispartofRenal Failure-
dc.identifier.scopus2-s2.0-0031853810-
Appears in Collections:Artigos, TCCs, Teses e Dissertações da Unesp

There are no files associated with this item.
 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.